Chemomab Therapeutics Ltd.
CMMB
$1.75
-$0.02-1.13%
NASDAQ
Corporate Info
Website
Phone Number
972 77 331 0156
Address
Building C
10th Floor
10 Habarzel Street
Tel Aviv-Yafo, 6158101
10th Floor
10 Habarzel Street
Tel Aviv-Yafo, 6158101
Country
Israel
Year Founded
2011
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
Business Description
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemic sclerosis. The company was founded in 2011 and is based in Tel Aviv-Yafo, Israel.